Completed Lungs & Breathing Pregnancy, Children & Inherited Conditions
Parent-determined oral montelukast therapy for preschool wheeze with stratification for arachidonate-5-lipoxygenase
About this grant
This summary is based on the grant title only — the full abstract was not available.
No substantive source abstract was published for this research project funded by MRC.
View the original record at the funder ↗
Researchers
Jonathan Grigg (Principal Investigator)
Related Research
Grants with similar aims, by meaning.
Parent-determined oral montelukast therapy for preschool wheeze with stratification for arachidonate-5-lipoxygenase (ALOX5) promoter genotype.
Development of non-invasive biomarkers to direct individualised management of preschool wheeze
Use of molecular profiling to determine optimal management for moderate to severe preschool wheeze
Preventing childhood Asthma using Prophylactic house dust mite Allergen immunotherapy
Identifying proteomic airway and plasma biomarkers in severe asthma
Original classification
IntramuralPlain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research. Is something wrong? Let us know